Accessibility StatementSkip Navigation NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), of the important October 21, 2025 lead plaintiff deadline. So what: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through ...

NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH ...

NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) for violations of the federal securities laws on behalf of investors who purchased or acquired Nutex securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). On August 22, 2025, a complaint was filed against the Company and cer ...

NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/nutex-health- ...

SAN FRANCISCO, Sept. 4, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with third-party billing firm HaloMD to submit ineligible insurance claims, misleading shareholders and tri ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Faruqi & Fa ...

Core Viewpoint - Investors in Nutex Health Inc. have the opportunity to lead a securities fraud class action lawsuit due to alleged undisclosed fraudulent activities and financial misstatements by the company [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit alleges that from August 8, 2024, to August 14, 2025, Nutex Health Inc. failed to disclose that HaloMD was involved in a scheme to defraud insurance companies, leading to unsustainable revenue [2]. - The company is accused of overstating its remediation of material weaknesses in internal controls over financial reporting, which affected its ability to account for stock-based compensation obligations [2]. - Nutex allegedly misclassified stock-based compensation obligations as equity instead of liabilities, increasing the risk of delayed financial report filings with the SEC [2]. - Positive statements made by the company regarding its business and financial prospects were claimed to be materially misleading and lacked a reasonable basis [2].

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. for alleged violations of securities laws, specifically related to misleading statements and fraudulent activities [1][4]. Group 1: Lawsuit Details - The lawsuit is initiated by the Schall Law Firm, focusing on violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - Investors who purchased Nutex securities between August 8, 2024, and August 14, 2025, are encouraged to participate in the lawsuit [2]. - The class has not yet been certified, meaning potential participants are not currently represented by an attorney [3]. Group 2: Allegations Against Nutex - The complaint alleges that Nutex made false and misleading statements regarding its financial health and operations [4]. - Nutex is accused of engaging in a scheme with HaloMD to defraud insurance companies, leading to unsustainable revenue [4]. - The company reportedly overstated its internal controls and failed to accurately calculate stock-based compensation obligations, resulting in materially misleading public statements [4].

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. for failing to disclose fraudulent activities by its third-party arbitration vendor, HaloMD, which has raised concerns about the legitimacy of the company's reported revenues and financial health [2][3]. Group 1: Allegations and Concerns - Nutex Health Inc. allegedly engaged in a scheme with HaloMD that defrauded insurance companies, leading to unsustainable revenue figures [2]. - The company is accused of overstating its ability to remediate internal control weaknesses, affecting its financial reporting and stock-based compensation calculations [2]. - A short report by Blue Orca Capital highlighted that Nutex's recent 20-fold share price surge was artificially inflated due to HaloMD's practices, raising doubts about the company's financial performance [3]. Group 2: Financial Impact - Following the announcement of a delay in filing quarterly financial statements due to incomplete accounting adjustments, Nutex's stock price dropped over 16% [4]. - The potential cessation of revenue benefits from HaloMD's billing practices could lead to a significant decline in Nutex's financial performance, possibly reverting its stock to penny-stock levels [3]. Group 3: Legal Proceedings - Shareholders are encouraged to participate in the class action lawsuit against Nutex Health Inc., with options to serve as lead plaintiff or remain an absent class member [5]. - Robbins LLP, the law firm handling the case, operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless a recovery is achieved [6].

NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 21, 2025. SO WHAT: If you purchased Nutex securities during the Class ...